Publications by authors named "Christoph Schliemann"

77Publications

Genome instability in multiple myeloma.

Leukemia 2020 11 10;34(11):2887-2897. Epub 2020 Jul 10.

Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

View Article and Find Full Text PDF
November 2020

Future Options of Molecular-Targeted Therapy in Small Cell Lung Cancer.

Cancers (Basel) 2019 May 17;11(5). Epub 2019 May 17.

Department of Medicine A, Hematology, Oncology and Pulmonary Medicine, University Hospital Muenster, 48149 Muenster, Germany.

View Article and Find Full Text PDF
May 2019

Are formalin-fixed and paraffin-embedded tissues fit for proteomic analysis?

J Mass Spectrom 2020 Aug 10;55(8):e4347. Epub 2019 Apr 10.

Core Unit Proteomics, Interdisciplinary Center for Clinical Research, Medical Faculty, University of Münster, Münster, Germany.

View Article and Find Full Text PDF
August 2020

Y-ibritumomab-tiuxetan as a therapeutic alternative for follicular lymphoma (FL): A single-center experience.

Eur J Haematol 2018 Oct 3;101(4):514-521. Epub 2018 Sep 3.

Department of Medicine A, Hematology, Oncology and Pulmonary Medicine, University Hospital Muenster, Muenster, Germany.

View Article and Find Full Text PDF
October 2018

AAA+ ATPases Reptin and Pontin as potential diagnostic and prognostic biomarkers in salivary gland cancer - a short report.

Cell Oncol (Dordr) 2018 Aug 5;41(4):455-462. Epub 2018 Jun 5.

Gerhard-Domagk-Institute for Pathology, University Hospital of Münster, Albert Schweitzer Campus 1 D17, 48149, Münster, Germany.

View Article and Find Full Text PDF
August 2018

Successful second allogeneic stem cell transplantation in a patient with T-lymphoblastic leukemia (T-ALL) relapsed as myeloid sarcoma.

Ann Hematol 2017 Jul 27;96(7):1201-1203. Epub 2017 Apr 27.

Department of Medicine A, Hematology and Oncology, University of Muenster, Albert-Schweitzer-Campus 1, 48149, Muenster, Germany.

View Article and Find Full Text PDF
July 2017

RNA-Guided CRISPR-Cas9 System-Mediated Engineering of Acute Myeloid Leukemia Mutations.

Mol Ther Nucleic Acids 2017 Mar 12;6:243-248. Epub 2017 Jan 12.

Department of Medicine A, University of Muenster, 48149 Muenster, Germany. Electronic address:

View Article and Find Full Text PDF
March 2017

Folding two lobes, you don't get a cup?

Blood 2016 09;128(9):1309

University Hospital Muenster.

View Article and Find Full Text PDF
September 2016

Tumor Growth Inhibition via Occlusion of Tumor Vasculature Induced by N-Terminally PEGylated Retargeted Tissue Factor tTF-NGR.

Mol Pharm 2015 Oct 31;12(10):3749-58. Epub 2015 Aug 31.

Department of Medicine A, Hematology, Oncology and Pneumology, ‡Integrated Functional Genomics (IZKF Muenster), and §Central Institute for Animal Experimentation, University of Muenster , Albert-Schweitzer-Campus 1, D-48129 Muenster, Germany.

View Article and Find Full Text PDF
October 2015

Low-Energy Ultrasound Treatment Improves Regional Tumor Vessel Infarction by Retargeted Tissue Factor.

J Ultrasound Med 2015 Jul;34(7):1227-36

Department of Medicine A, Hematology, Oncology, and Pneumology (C.B., R.R., H.H., C.S., C.M.-T., R.M.M., W.E.B., C.S.), Department of Cardiovascular Medicine, Division of Cardiology (J.S.), and Cluster of Excellence EXC 1003, Cells in Motion (W.E.B.), University of Muenster, Muenster, Germany; Institute of Medical Engineering, Ruhr University, Bochum, Germany (S.D., G.S.); and Nijmegen Center for Mitochondrial Disorders, Radboud University Medical Center, Nijmegen, the Netherlands (M.M.).

View Article and Find Full Text PDF
July 2015

Antibody-based delivery of interleukin-2 to neovasculature has potent activity against acute myeloid leukemia.

Sci Transl Med 2013 Sep;5(201):201ra118

Department of Chemistry and Applied Biosciences, ETH Zürich, Wolfgang-Pauli-Strasse 10, CH-8093 Zurich, Switzerland.

View Article and Find Full Text PDF
September 2013

Analysis of a novel highly metastatic melanoma cell line identifies osteopontin as a new lymphangiogenic factor.

Int J Oncol 2012 Oct 6;41(4):1455-63. Epub 2012 Jul 6.

Department of Medicine, Hematology and Oncology, University Hospital Muenster, D-48129 Muenster, Germany.

View Article and Find Full Text PDF
October 2012

The accessible cerebral vascular proteome in a mouse model of cerebral β-amyloidosis.

J Proteomics 2011 Apr 22;74(4):539-46. Epub 2011 Jan 22.

Department of Chemistry and Applied Biosciences, ETH Zürich, Zurich, Switzerland.

View Article and Find Full Text PDF
April 2011

The immunocytokine F8-IL2 improves the therapeutic performance of sunitinib in a mouse model of renal cell carcinoma.

J Urol 2010 Dec 28;184(6):2540-8. Epub 2010 Oct 28.

Department of Chemistry and Applied Biosciences, Eidgenössische Technische Hochschule Zürich, Zürich, Switzerland.

View Article and Find Full Text PDF
December 2010

Antibody-based vascular tumor targeting.

Recent Results Cancer Res 2010 ;180:201-16

Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology Zürich, Zürich, Switzerland.

View Article and Find Full Text PDF
March 2010

A proteomic approach for the identification of vascular markers of liver metastasis.

Cancer Res 2010 Jan 8;70(1):309-18. Epub 2009 Dec 8.

Department of Chemistry and Applied Biosciences, ETH Zürich, Zurich, Switzerland.

View Article and Find Full Text PDF
January 2010

In vivo biotinylation of the vasculature in B-cell lymphoma identifies BST-2 as a target for antibody-based therapy.

Blood 2010 Jan 10;115(3):736-44. Epub 2009 Nov 10.

Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich, Zurich, Switzerland.

View Article and Find Full Text PDF
January 2010

Comparative immunohistochemical staining of atherosclerotic plaques using F16, F8 and L19: Three clinical-grade fully human antibodies.

Atherosclerosis 2010 Feb 30;208(2):382-9. Epub 2009 Jul 30.

Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology Zurich, Wolfgang-Pauli-Strasse 10, 8093 Zurich, Switzerland.

View Article and Find Full Text PDF
February 2010

Three clinical-stage tumor targeting antibodies reveal differential expression of oncofetal fibronectin and tenascin-C isoforms in human lymphoma.

Leuk Res 2009 Dec 22;33(12):1718-22. Epub 2009 Jul 22.

Institute of Pharmaceutical Sciences, ETH Zürich, Wolfgang-Pauli-Strasse 10, 8093 Zürich, Switzerland.

View Article and Find Full Text PDF
December 2009

Complete eradication of human B-cell lymphoma xenografts using rituximab in combination with the immunocytokine L19-IL2.

Blood 2009 Mar 12;113(10):2275-83. Epub 2008 Nov 12.

Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology Zürich, Zürich, Switzerland.

View Article and Find Full Text PDF
March 2009

Generation of fusion proteins for selective occlusion of tumor vessels.

Curr Drug Discov Technol 2008 Mar;5(1):1-8

Department of Medicine / Hematology and Oncology, University of Muenster, Albert-Schweitzer-Strasse 33, D-48129 Muenster, Germany.

View Article and Find Full Text PDF
March 2008

Expression of VEGF-C and its receptor VEGFR-3 in the bone marrow of patients with acute myeloid leukaemia.

Leuk Res 2008 Jun 19;32(6):954-61. Epub 2007 Nov 19.

Department of Medicine/Hematology and Oncology, University of Muenster, Albert-Schweitzer-Strasse 33, D-48129 Muenster, Germany.

View Article and Find Full Text PDF
June 2008

Antibody-based targeting of the tumor vasculature.

Biochim Biophys Acta 2007 Dec 25;1776(2):175-92. Epub 2007 Aug 25.

Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology Zürich, Wolfgang-Pauli-Strasse 10, HCI G396, 8093 Zürich, Switzerland.

View Article and Find Full Text PDF
December 2007

Expression of angiopoietins and their receptor Tie2 in the bone marrow of patients with acute myeloid leukemia.

Haematologica 2006 Sep;91(9):1203-11

Department of Medicine/Hematology and Oncology, and the IZKF Muenster, University of Muenster, Albert-Schweitzer-Strasse 33, D-48129 Muenster, Germany.

View Article and Find Full Text PDF
September 2006